A standard lipid panel measures the wrong thing well
The lipid panel was built to triage heart-attack risk in a clinic, and it reports concentrations — how much cholesterol is dissolved in the blood. But atherosclerosis is not driven by cholesterol mass; it is driven by the number of atherogenic particles colliding with the artery wall. A standard panel can read "fine" while particle count is high. This chapter is about reading the markers that actually count particles.
LDL-C, HDL-C, and triglycerides — the canon, and their limits
The familiar numbers still matter as a baseline: LDL-C optimal below 100 mg/dL, HDL-C above 50 mg/dL, triglycerides below 100 mg/dL. But each has a catch. LDL-C is usually calculated, and the calculation is unreliable when triglycerides exceed ~400 mg/dL or the draw is non-fasting. HDL is a marker of metabolic health to read, not a lever to pharmacologically force — very high genetic HDL is not protective. Triglycerides respond fast to diet and are the most fasting-sensitive number on the panel; a recent meal can inflate them 30–50%.
Triglyceride-to-HDL ratio — a free insulin-resistance read
Divide fasting triglycerides by HDL (same units) and you get one of the most useful free numbers in all of bloodwork: a proxy for insulin resistance and for the small, dense LDL phenotype. Optimal is below 1.5; above 3.0–3.5 strongly suggests insulin resistance even when fasting glucose looks normal. It is metabolic information hiding inside a cardiac panel.
ApoB — the marker that should anchor the read
One apolipoprotein-B molecule sits on every atherogenic particle — every LDL, VLDL, IDL, and Lp(a). So ApoB is a direct count of the particles that cause atherosclerosis, and it is the single best marker on the panel. Optimal in a longevity context is roughly below 80 mg/dL. Its real value is catching discordance: when LDL-C reads acceptable but ApoB is high, the particles are small and numerous and the risk is real despite a reassuring cholesterol number. ApoB needs no fasting, uses a cheap standardized assay, and when it disagrees with LDL-C, ApoB wins. Pull it at least once.
Lp(a) — the genetic, once-in-a-lifetime test
Lipoprotein(a) is a largely genetic, independent, causal driver of cardiovascular and aortic-valve disease — and almost nobody is tested for it. You measure it once, because it barely moves with behavior; the value is in knowing, then managing every other risk factor harder if it is high. The unit trap is critical and safety-relevant: mg/dL and nmol/L are not interchangeable (nmol/L is the modern preferred unit, and there is no clean universal conversion). High-risk is roughly ≥50 mg/dL or ≥125 nmol/L. Always confirm which unit your lab reported before you interpret the number.
Non-HDL cholesterol — the best proxy from a basic panel
If ApoB isn't available, non-HDL cholesterol (total minus HDL) is the best atherogenic proxy you can compute from any standard panel at zero extra cost — it captures remnant and VLDL cholesterol that LDL-C alone misses, and it tracks ApoB far more closely than LDL-C does. Target below ~100–110 mg/dL in a longevity context.
Reading the panel together
Anchor on ApoB (or non-HDL if ApoB isn't run), read the triglyceride-to-HDL ratio for the metabolic story, and get Lp(a) once for the genetic baseline — then let LDL-C, HDL, and triglycerides fill in the texture. For enhanced readers: oral 17-alpha-alkylated compounds are the harshest on this panel, suppressing HDL and raising ApoB within weeks, which is exactly why ApoB is the marker to watch on and off cycle — a sustained high ApoB is a real risk signal, not an acceptable cost.
Educational only; not medical or dosing advice. Fast 10–12 hours before the triglyceride-dependent values.